
Opglim MP1 Tablet SR
Marketer
Opsiscare Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Opglim MP1 Tablet SR
Glimepiride-Metformin extended-release tablets manage blood glucose in adults with type 2 diabetes. This medication complements dietary changes and exercise to enhance glycemic control. It improves insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen. Take it with food to prevent stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; monitor your blood sugar carefully. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose any kidney, liver, or heart conditions before starting treatment. Pregnant or breastfeeding individuals should consult their physician. Kidney function tests will be conducted prior to treatment initiation. Limit alcohol consumption to minimize side effects.
Primary Ingredients of Opglim MP1 Tablet SR
No text provided to rephrase.
Uses of Opglim MP1 Tablet SR
Managing type 2 diabetes
Major Benefits of Opglim MP1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Opglim MP1 Tablet SR should be administered with a meal.
Common Side effects of Opglim MP1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Opglim MP1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Opglim MP1 Tablet SR whole; avoid chewing, crushing, or breaking it. It should be administered with food.
How Opglim MP1 Tablet SR works:
Opglim MP1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct pathways to enhance blood glucose management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Opglim MP1 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Opglim MP1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Opglim MP1 Tablet is likely unsuitable for use while breastfeeding. Preliminary research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Opglim MP1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Opglim MP1 Tablet SR; dosage modification may be necessary. Medical advice is recommended. Opglim MP1 Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Opglim MP1 Tablet SR :
Should you forget to take your Opglim MP1 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Opglim MP1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
